Financials
Income statement
Fiscal date | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 |
---|---|---|---|---|
Total reported revenue | 1.6B | 1.7B | 1.5B | 1.7B |
Cost of revenue | 496M | 481M | 443M | 492M |
Gross profit | 1.1B | 1.2B | 1.1B | 1.2B |
Operating expense | ||||
Research & development | 247M | 257M | 252M | 271M |
Selling general and admin | 525M | 562M | 546M | 538M |
Other operating expenses | — | — | — | — |
Operating income | 373M | 358M | 300M | 367M |
Non operating interest income | ||||
Income | 20M | 27M | 36M | 32M |
Expense | 12M | 15M | 16M | 16M |
Other income expense | -11M | -10M | -21M | -3M |
Pretax income | 370M | 360M | 299M | 380M |
Tax provision | 71M | 61M | 51M | 89M |
Net income | 299M | 299M | 248M | 291M |
Basic EPS | 1.5 | 1.5 | 1.2 | 1.4 |
Diluted EPS | 1.4 | 1.4 | 1.2 | 1.4 |
Basic average shares | 226.4M | 226.4M | 228.6M | 228.6M |
Diluted average shares | 230.9M | 233.1M | 235.3M | 235.3M |
EBITDA | 457M | 451M | 396M | 461M |
Net income from continuing op. | 299M | 299M | 248M | 291M |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |